Wikidata

(Q80251510)

English

A Phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapy

scientific article published on 02 May 2007

In more languages

Statements

title
A Phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapy (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17473981
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17473981%20AND%20SRC:MED&resulttype=core&format=json
retrieved
30 December 2019

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q80251510&oldid=1955690290"